Oppenheimer analyst Colin Rusch downgrades Tesla (NASDAQ:TSLA) from Outperform to Perform.
Oppenheimer Downgrades Tesla to Perform
Oppenheimer analyst Colin Rusch downgrades Tesla (NASDAQ:TSLA) from Outperform to Perform.
Related Posts
Microsoft To Rally Over 13%? Here Are 10 Other Analyst Forecasts For Monday
April 24, 8:50 AM
Deutsche Bank cut the price target for Autoliv, Inc. (NYSE: ALV) from $113 to $110. Deutsche Bank analyst Emmanuel Rosner maintained a Buy rating. Autoliv shares fell 0.9% to $86.32 in pre-market trading.
JMP Securities Maintains Market Outperform on Pharvaris, Raises Price Target to $23
January 11, 9:38 AM
JMP Securities analyst Jonathan Wolleben maintains Pharvaris (NASDAQ:PHVS) with a Market Outperform and raises the price target from $22 to $23.
Creative Medical Technology Holdings Announces Next Milestone Achievements In ImmCelz Platform Development; Advancements May Result In Ability To Treat A Broader Patient Population With Immune Disorders
May 22, 8:43 AM
Advancements May Result in Ability to Treat a Broader Patient Population with Immune DisordersPHOENIX, May 22, 2023 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the